Meeting Banner
Abstract #4875

Gd-enhanced MRI after therapeutic ferumoxytol for iron deficiency anemia - An in-vitro study for optimal contrast timing and dose determination.

Sandeep Arora 1 , Judy Yee 1 , David Saloner 1 , Rizwan Aslam 1 , and Thomas Hope 1

1 Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California, United States

Therapeutic ferumoxytol injections can confound subsequently performed magnetic resonance imaging using gadolinium based contrast agents due to its superparamagnetic effects. In this in vitro study, we image various concentrations of ferumoxytol and gadolinium to determine concentration of ferumoxytol which will not affect arterial enhancement in subsequent contrast enhanced scans. Our images demonstrate that significant enhancement can be seen after single dose gadolinium enhanced scans two half-lives with initial ferumoxytol concentration being 300 microgram/ml. Even after one half-life, significant enhancement can be seen with double or triple dosing of gadolinium based contrast agents.

This abstract and the presentation materials are available to members only; a login is required.

Join Here